Skip to main content
Premium Trial:

Request an Annual Quote

Evonik Licenses Integrated Genomics' Bioinformatics Platform

NEW YORK (GenomeWeb News) – Integrated Genomics today said that it has licensed its Ergo bioinformatics platform to Evonik Industries for use in optimizing production strains and finding new methods for high-yield production of specialty chemicals.
Integrated Genomics said that the Ergo platform is optimized for analysis of microorganisms and integrates biological data from genomics, biochemistry, gene expression studies, genetics, and literature. It contains data on more than 1,500 genomes in various stages of completion, the Chicago-based firm said.
Thomas Haas, director of Evonik's Science-to-Business Center for biotechnology in Marl, Germany, said Evonik expects the Ergo platform to “assist us in developing new production strains for higher and more cost-effective production of biological compounds.”
Financial terms of the license were not disclosed.

Filed under

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.